≡ Menu


Kwan C, Reimers J, O’Gorman C, Bird R, Brown H. Multi-territorial Strokes in the Setting of Autoimmune Heparin Induced Thrombocytopaenic Thrombotic Syndrome. BMJ case reports 2021, in press.

Clarke L, Bukhari W, O’Gorman C, et al. Response to treatment in NMOSD: the Australasian experience. Multiple Sclerosis and Related Disorders 2021, https://doi.org/10.1016/j.msard.2021.103408.

Warren N, Eyre-Watt B, Pearson E, O’Gorman C, Watson E, Lie D, Siskind D. Tardive seziures following electroconvulsive therapy. The journal of ECT 2021, in press.

Clarke L, Arnett S, Bukhari W, Khalilidehkordi E, Jimenez Sanchez S, O’Gorman C, et al. MRI patterns distinguish AQP4 antibody positive neuromyelitis optica spectrum disorder from multiple sclerosis. Frontiers in Neurology 2021, 12, 1554.

Bukhari et al. NMOSD and MS prevalence in the indigenous populations of Australia and New Zealand. Journal of Neurology 2021, https://doi.org/10.1007/s00415-021-10665-9 

Beer R, O’Gorman C, Horwood K, Blum S. A case of IVIg responsive paraneoplastic SOX1 peripheral neuropathy in a male with breast carcinoma. Journal of Neuroimmunology 2021, 352, 577492. 

Chan F, Warren N, O’Gorman C, Swayne A, Blum S. VGKC blanket testing in first episode psychosis – diagnostic nihilism? Australian and New Zealand Journal of Psychiatry 2021 Jan 9; 4867420983454.

Kwan C, Sia A, O’Gorman C. Status epilepticus from GABABR encephalitis due to de novo mixed small cell and adenocarcinoma of the prostate. BMJ case reports 2020; 13(11):e238172.

Swayne A, Warren N, Prain K, Gillis D, O’Gorman C, Tsang BK, Muller C, Broadley S, Adam RJ, McCombe PA, Wong RC, Blum S. An Australian state-based cohort study of autoimmune encephalitis cases detailing clinical presentation, investigation, results and response to therapy. Frontiers in Neurology 2021 Feb 22;12:607773.

Warren N, Flavell J, O’Gorman C et al. Evaluation of proposed anti-N-Methyl-D-Aspartate receptor encephalitis clinical diagnostic criteria in psychiatric patients. Acta Psychiatrica Scandinavica 2020; 142(1):52-57.

Khalilidehkordi E, Clarke L, Arnett S, Bukhari W, Jiminez-Sanchez S, O’Gorman C, et al. Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation. Frontiers in Neurology 2020; 11:537.

Warren N, Flavell J, O’Gorman C, Swayne A, Blum S, Kisely S, Siskind D. Screening for anti-NMDAR encephalitis in psychiatry. J Psychiatr Res 2020; 125:28-32.

Bukhari W, Clarke L, O’Gorman Cet al.The clinical profile of NMOSD in Australia and New Zealand. J Neurol 2020; 267:1431-1443.

Warren N, O’Gorman C, McKeon G, Swayne A, Blum S, Siskin D. Psychiatric management of anti-NMDAR encephalitis: A cohort analysis. Psychological Medicine 2019; 1-6.

Prain K, Woodhall M, Vincent A et al. AQP4 antibody sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD. Frontiers in Neurology 2019, 10:1028. doi: 10.3389/fneur.2019.01028

Warren N, Swayne A, Siskind D, O’Gorman C, Prain K, Gillis D, Blum S. Serum and CSF anti-NMDAR antibody testing in psychiatry. Journal of Neuropsychiatry and Clinical Neurosciences 2019 published online 18 Sep 2019. https://doi.org/10.1176/appi.neuropsych.19030079

Tea F, Lopez JA, Ramanathan S, et al. Characterization of the epitope, affinity, and binding sensitivity of the human MOG antibody response. Acta Neuropathologica Communications 2019, 7:145. https://doi.org/10.1186/s40478-019-0786-3

Gillinder L, Warren N, Hartel G, Dionisio S, O’Gorman C. EEG findings in NMDA encephalitis – a systematic review. Seizure – European Journal of Epilepsy 2019, 65:20-24. https://doi.org/10.1016/j.seizure.2018.12.015

Warren N, Grote V, O’Gorman C, Siskind D. Electroconvulsive Therapy for Anti-N-methyl-d-aspartate (NMDA) Receptor Encephalitis: A Systematic Review of Cases. Brain Stimulation 2019 Mar – Apr;12(2):329-334. https://doi.org/10.1016/j.brs.2018.11.016

Warren N, Siskind D, O’Gorman C. Refining the psychiatric syndrome of anti-N-methyl-D-aspartate (NMDA) receptor encephalitis. Acta Psychiatrica Scandinavica 2018, 138(5):401-408. https://doi.org/10.1111/acps.12941

Warren N, O’Gorman CM, Hume Z, Kisely S, Siskind D. Delusions in Parkinson’s Disease: A systematic review of published cases. Neuropsychology Review 2018, Neuropsychol Rev. 2018 Aug 2. https://doi.org/10.1007/s11065-018-9379-3

O’Gorman CM*, Kassardjian CD*, Sorenson E. Musculocutaneous neuropathy. Muscle Nerve 2018, Jul 20. https://doi.org/10.1002/mus.26186 *joint 1st authors

Devlin M, Swayne A, Newman M, O’Gorman C, Brown H, Ong B, Robertson T, Airey C, Blum S. A case of immune-mediated encephalitis related to daclizumab therapy. Multiple Sclerosis Journal 2018, Aug 3:1352458518792403. https://doi.org/10.1177/1352458518792403

Kee R, O’Gorman C. Teaching Video NeuroImages: The pathologic deep abdominal reflex.
Neurology Nov 2017, 89 (20) e245; DOI: 10.1212/WNL.0000000000004651

Warren N, O’Gorman C, Lehn A, Siskind D. Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases. J Neurol Neurosurg Psychiatry 2017, doi: 1136/ jnnp-2017-31598

Lehn AC, O’Gorman C, Olson S, Salari M. Thalamic ventral intermediate nucleus deep brain stimulation for orthostatic tremor. Tremor Other Hyperkinet Mov. 2017; 7. doi:7916/D8280JHR

Bukhari W, Prain KM, Waters P, O’Gorman CM, et al. Incidence and prevalence of NMOSD in Australia and New Zealand J Neurol Neurosurg Psychiatry Published Online First: 26 May 2017. doi: 10.1136/jnnp-2016-314839

O’Gorman CM, Weikamp JG, Baria M, Van den Engel-Hoek L, Kassardjian C, van Alfen N, Boon AJ. Detecting fasciculations in cranial nerve innervated muscles with ultrasound in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2017 Apr 29. doi:10.1002/mus.25676.

O’Gorman CM, O’brien TG, Boon AJ. Utility Of diaphragm ultrasound in myopathy. Muscle Nerve. 2017 Mar;55(3):427-429. doi: 10.1002/mus.25429.

O’Gorman CM, Broadley SA. Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia. J Neurol Sci 2016; 219-223. doi: 10.1016/j.jns.2016.09.057

Boon AJ, OʼGorman C. Ultrasound in the Assessment of Respiration. J Clin Neurophysiol. 2016 Apr;33(2):112-9. doi: 10.1097/WNP.0000000000000240.

O’Gorman CM, Lindell EP, Van Gompel JJ, Klaas JP. A tardy tongue palsy: Delayed post-traumatic isolated unilateral hypoglossal neuropathy. Published ahead of print October 29, 2015 Neurol Clin Pract 10.1212/CPJ.0000000000000193.

Kassardjian CD*, O’Gorman CM*, Sorenson EJ. The risk of iatrogenic pneumothorax after electromyography. Muscle Nerve 2016;53(4):518-21. doi: 10.1002/mus.24883. PMID: 26333600.

O’Gorman C, Cascino GD. Teaching NeuroImages: EEG pattern associated with a skull osteolytic lesion in breast cancer. Neurology 2014 Sep 9;83(11):e117-8. doi: 10.1212/WNL.0000000000000783.

O’Gorman C, Broadley SA. Smoking and multiple sclerosis: evidence for latitudinal and temporal variation. J Neurol 2014;261(9):1677-83. doi: 10.1007/s00415-014-7397-5.

O’Gorman, C. M., Bower, J. H., Matsumoto, J. Y., Kantarci, O. H. and Kumar, N. (2014), When Drinking Makes the Tremor Worse: A Task-Specific Orolingual Tremor. Movement Disorders Clinical Practice 2014;1(3): 237–239. doi: 10.1002/mdc3.12041

O’Gorman C, Bukhari W, Todd A, Freeman S, Broadley SA. Smoking increases the risk of multiple sclerosis in Queensland, Australia. J Clin Neurosci 2014;21(10):1730-3. doi: 10.1016/j.jocn.2014.01.009.

O’Gorman C. Environmental risk factors for multiple sclerosis (Part I). Revista Española de Esclerosis Múltiple 2013;28:19-36.

O’Gorman C. Environmental risk factors for multiple sclerosis (Part II). Revista Española de Esclerosis Múltiple 2014;29:5-25

O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 2013;40(1):1-12. doi: 10.1159/000341902.

O’Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 2012;13(9):11718-52. doi: 10.3390/ijms130911718.

Fitzpatrick E, Hohl N, Silburn P, O’Gorman C, Broadley SA.. Case-control study of blink rate in Parkinson’s disease under different conditions. J Neurol 2012;259(4):739-744

O’Gorman C, Freeman S, Taylor BV, Butzkueven H; Australian and New Zealand MS Genetics Consortium (ANZgene), Broadley SA. Familial recurrence risks for multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry 2011;82(12):1351-4. doi: 10.1136/jnnp.2010.233064.

O’Gorman CM, Freeman S, Broadley SA. Use of the Addenbrooke’s Cognitive Examination in Multiple Sclerosis [Abstract]. J Clin Neurosci 2010;17(12):1617